Torley Helen bought HALO
February 16, 2026 · Form 4 insider transaction
Torley Helen bought 51,171 shares of Halozyme Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
51,171
Price
$0.00
Total value
N/A
InsiderTorley Helen
RoleOfficer, Director
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateFebruary 16, 2026
Filing dateFebruary 17, 2026
Shares owned after777,336
OwnershipDirect
10b5-1 planNo
AmendedNo